Vote Scores
Filings read through

How funds voted at Ikena Oncology, Inc.

Filers reporting
12, year to 30 June 2026
Latest meeting on file
Meetings on file
4

In the year to 30 June 2026, 12 filers on Form N-PX reported votes at Ikena Oncology, Inc.. The votes fall in 2 meetings. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 67 marks to the ballot items, each with or against management. 77.6% of the marks are with management.

On say-on-pay, 2 of the 3 reporting filers that marked the item voted against management. This is 66.7% of the filers. Of the reported shares, 43.5% went against management. The median of the 3,799 companies on this site with a say-on-pay item is 6.6% of filers and 2.9% of reported shares.

By filers reporting in the year to 30 June 2026, Ikena Oncology, Inc. was number 10,679 of 11,972 companies with a page and votes in that year. No filer reported votes at Ikena Oncology, Inc. in the year to 30 June 2025, so this page gives no change from that year. In all seasons on file, category DIRECTOR ELECTIONS is 36.9% of the vote records at Ikena Oncology, Inc.. At all companies on this site, it is 52.2%.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 7 Jun 2024

41 filers reported votes at this meeting in the year to 30 June 2024. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 41.5% of the reported votes are for. 35 filers withheld from or voted against at least one nominee.

    130 vote records from 41 filers. 16 of the 41 filers that marked the item voted against management.

    • Positions of 19 fund families
    • For 2
    • Abstain or withhold 7
    • Split or no vote 10
    • Against management 7
  2. Item 2: Audit-related items (auditor ratification)

    65 vote records from 41 filers. 0 of the 41 filers that marked the item voted against management.

    • Positions of 19 fund families
    • For 19

Positions of the fund families at the meeting of 7 Jun 2024

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Ikena Oncology, Inc., meeting of 7 Jun 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund familyAuditor
BlackRock and iSharesFor
Charles SchwabFor
DWSFor
EquitableFor
FidelityFor
Global XFor
Guggenheim and RydexFor
John Hancock and ManulifeFor
Lincoln FinancialFor
Morgan Stanley, Eaton Vance and CalvertFor
NationwideFor
Northern Trust and FlexSharesFor
Nuveen and TIAAFor
Pacific Life fundsFor
PrincipalFor
ProShares and ProFundsFor
State Street and SPDRFor
T. Rowe PriceFor
VanguardFor

Every meeting on file

Meetings of Ikena Oncology, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 20268466.7%
year to 30 June 20261070.0%
year to 30 June 2024412not reported
year to 30 June 2024462not reported

Say-on-pay, season by season

Say-on-pay at Ikena Oncology, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 20261266.7%43.5%
year to 30 June 202450not reportednot reported
Ikena Oncology, Inc. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against management66.7%6.6%
Reported shares against management43.5%2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Ikena Oncology, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS19536.9%
SECTION 14A SAY-ON-PAY VOTES50.9%
AUDIT-RELATED9117.2%
EXTRAORDINARY TRANSACTIONS132.5%
CAPITAL STRUCTURE9317.6%
COMPENSATION397.4%
CORPORATE GOVERNANCE9317.6%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Ikena Oncology, Inc.. https://votescores.com/company/ikena-oncology-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Ikena Oncology, Inc. are on file?
4 meetings are on file, from 11 Oct 2023 to 16 Jun 2026. 2 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Ikena Oncology, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Ikena Oncology, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Ikena Oncology, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .